Your healthcare provider will advise on when to start the new treatment relative to your last Trulicity dose
Cardiovascular effects of GLP-1 and GLP-1-based therapies:Implications for the cardiovascular continuum in diabetes
For some individuals, they may: Help regulate blood sugar levels Reduce binge-eating symptoms Reduce inflammation Improve mobility and reduce joint pain At the same time, there are valid concerns and complicated feelings surrounding their growing prominence, particularly within eating disorder recovery spaces
Associations of discontinuation with safety, tolerability, effectiveness, health factors, sociodemographic characteristics, and access were considered
Daily dosing provides steady appetite regulation and eliminates concerns related to injections, making it a preferred option for individuals seeking a non-invasive approach
Once-daily subcutaneous injection for 812 weeks, optionally extended to ~16 weeks